Satellos Bioscience Inc. Common Stock (NASDAQ: MSLE) — Healthcare · Share Price, Chart & Market Data
About: Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.98 (+2.50%)
MSLESatellos Bioscience Inc. Common Stock
Loading watchlist status…
Trade MSLE now
Satellos Bioscience Inc. Common Stock share price
MSLE price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:55 am GMT+0
MSLE price performance
-10.856%
5D
-1.273%
1M
-39.941%
YTD
-39.941%
1Y
MSLE price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:55 am GMT+0
MSLE details
MSLE Market Signals